Prostate Cancer Vaccine | search
Click here to view Prostate Cancer Vaccine news from 60+ newspapers.
Bookmark or Share- Immunotherapy for Prostate Cancer | Johns Hopkins MedicineImmunotherapy for prostate cancer works by helping a patient’s own immune system fight back against cancer cells. One immune therapy that has been approved by the FDA is a vaccine called sipuleucel-T (Provenge), which spurs a patient’s immune system to attack prostate cancer cells. The vaccine is tailored to match each patient’s own ...
- Vaccines as treatments for prostate cancer - NatureProstate cancer is a leading cause of death in men worldwide. For over 30 years, growing interest has focused on the development of vaccines as treatments for prostate cancer, with the goal of ...
- Clinical advances and ongoing trials of mRNA vaccines for cancer ...An RNActive vaccine encoding six prostate cancer-specific antigens (CV9104) was investigated in a placebo-controlled phase 1/2 study in patients with metastatic castration-resistant prostate cancer. The vaccine was clinically safe for the patients but did not improve overall survival and progression-free survival compared with the placebo. 12.
- New urine test has higher diagnostic accuracy for prostate cancerA new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a study published April 18 in JAMA Oncology.The urine test, MyProstateScore 2.0 (MPS2), was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection of ...
- Provenge Advanced Prostate Cancer Treatment - UCLA HealthProvenge is a systematic therapeutic vaccine treatment that works throughout the entire body that idenifies and eliminates only cancerous cells.Studies have shown that in patients with metastatic prostate cancer, Provenge has allowed men to live longer with minimal side effects, and reducing the risk of death by 22.5%.
More
